Trial · NCT00894387
Results by group66
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 66
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Aliskiren | Secondary Composite Endpoint | 283 | Participants | |
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Placebo | Secondary Composite Endpoint | 301 | Participants | |
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Aliskiren | Cardiovascular death | 126 | Participants | |
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Placebo | Cardiovascular death | 137 | Participants | |
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Aliskiren | Heart faliure re-hospitalization | 212 | Participants | |
| Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 12 Months | Placebo | Heart faliure re-hospitalization | 224 | Participants | |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Aliskiren | 1 Month (n= 574, 571) | 24.13 | Standard Error 0.903 | units on a scale |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Placebo | 1 Month (n= 574, 571) | 23.58 | Standard Error 0.908 | units on a scale |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Aliskiren | 6 Months (n= 485, 474) | 26.54 | Standard Error 1.004 | units on a scale |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Placebo | 6 Months (n= 485, 474) | 24.51 | Standard Error 1.016 | units on a scale |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Aliskiren | 12 Months (n= 241, 230) | 24.82 | Standard Error 1.268 | units on a scale |
| Change From Baseline in the Clinical Summary Score to 1 Month, 6 Months and 12 Months | Placebo | 12 Months (n= 241, 230) | 24.70 | Standard Error 1.291 | units on a scale |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Aliskiren | Cardiovascular event | 209 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Placebo | Cardiovascular event | 233 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Aliskiren | Cardiovascular death | 77 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Placebo | Cardiovascular death | 85 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Aliskiren | Heart faliure re-hospitalization | 153 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Placebo | Heart faliure re-hospitalization | 166 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Aliskiren | All-cause myocardial infarction | 14 | Participants | |
| Time to Event Analysis: Number of Patients With First Cardiovascular (CV) Event Hospitalized for an Acute Heart Faliure (AHF) Event Within 6 Months | Placebo | All-cause myocardial infarction | 23 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00894387/results